Advertisement

Advertisement

2020 Annual Meeting of the Society for Immunotherapy of Cancer

Skin Cancer

By Caroline Helwick  / December 25, 2020  / 2020 Annual Meeting of the Society for Immunotherapy of Cancer

Intratumoral Injections May Boost Neoadjuvant Response in Resectable Melanoma

Studies reported at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting, which was held virtually, showed promise for the use of intratumoral injections of novel immunotherapies in trea...

Skin Cancer

By Caroline Helwick  / December 25, 2020  / 2020 Annual Meeting of the Society for Immunotherapy of Cancer

Novel Combination Under Study in First-Line Treatment of Metastatic Melanoma

A first-line regimen combining the novel interleukin-2 (Il-2) agonist bempegaldesleukin (NKTR-214) with nivolumab showed encouraging clinical activity in patients with metastatic melanoma in the phase...

Advertisement

Advertisement




Apr
20
Today In Oncology
Alectinib Approved as Adjuvant Treatment for ALK-Positive Non–Small Cell Lung Cancer
Professional Societies Introduce New Evidence-Based Guidelines on Testing Immunotherapy Biomarkers in NSCLC
Accelerated Aging May Be a Risk Factor for Early-Onset Cancers in Younger Generations
Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers
Novel SPECT/CT Imaging Technique Under Study in Prostate Cancer
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside